Several founder mutations have previously been identified among the Dutch16 including founder mutations in the BRCA1/2 (hereditary breast cancer), LDLR (dyslipidemia) and Tau (dementia) genes. The gene discussed is MAPT; the disease is Hereditary breast cancer.